Eswara Naga Hanuma Kumar Ghali, Vijian Dhevan, Shravan K Narmala, Meena Jaggi, Subhash C Chauhan, Murali M Yallapu
{"title":"COVID-19大流行时期的突破性药物。","authors":"Eswara Naga Hanuma Kumar Ghali, Vijian Dhevan, Shravan K Narmala, Meena Jaggi, Subhash C Chauhan, Murali M Yallapu","doi":"10.4155/fdd-2022-0002","DOIUrl":null,"url":null,"abstract":"Eswara Naga Hanuma Kumar Ghali1,2, Vijian Dhevan3, Shravan K Narmala4, Meena Jaggi1,2, Subhash C Chauhan1,2 & Murali M Yallapu*,1,2 1Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA 2South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA 3Department of Surgery, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA 4DHR Health Hematology Oncology Institute, DHR Health, Edinburg, TX 78539, USA *Author for correspondence: Tel.: +956 296 1734; murali.yallapu@utrgv.edu","PeriodicalId":73122,"journal":{"name":"Future drug discovery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/4b/fdd-04-69.PMC8842712.pdf","citationCount":"0","resultStr":"{\"title\":\"Breakthrough medicines during the COVID-19 pandemic era.\",\"authors\":\"Eswara Naga Hanuma Kumar Ghali, Vijian Dhevan, Shravan K Narmala, Meena Jaggi, Subhash C Chauhan, Murali M Yallapu\",\"doi\":\"10.4155/fdd-2022-0002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Eswara Naga Hanuma Kumar Ghali1,2, Vijian Dhevan3, Shravan K Narmala4, Meena Jaggi1,2, Subhash C Chauhan1,2 & Murali M Yallapu*,1,2 1Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA 2South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA 3Department of Surgery, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA 4DHR Health Hematology Oncology Institute, DHR Health, Edinburg, TX 78539, USA *Author for correspondence: Tel.: +956 296 1734; murali.yallapu@utrgv.edu\",\"PeriodicalId\":73122,\"journal\":{\"name\":\"Future drug discovery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/4b/fdd-04-69.PMC8842712.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future drug discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/fdd-2022-0002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/fdd-2022-0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Breakthrough medicines during the COVID-19 pandemic era.
Eswara Naga Hanuma Kumar Ghali1,2, Vijian Dhevan3, Shravan K Narmala4, Meena Jaggi1,2, Subhash C Chauhan1,2 & Murali M Yallapu*,1,2 1Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA 2South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA 3Department of Surgery, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA 4DHR Health Hematology Oncology Institute, DHR Health, Edinburg, TX 78539, USA *Author for correspondence: Tel.: +956 296 1734; murali.yallapu@utrgv.edu
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
